Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

2022139 citationsJournal Articlebronze Open Access

Authors

Evan J. Anderson · Emory University

C. Buddy Creech · Atlanta VA Medical Center

Vladimir Berthaud · Meharry Medical College

Arin Piramzadian · Clinical Solutions

Kimball A. Johnson · Atlanta VA Medical Center

Marcus Zervos · Henry Ford Health System

Fredric Garner ·

Abstract

Two 25-μg doses of the mRNA-1273 vaccine were found to be safe in children 6 months to 5 years of age and elicited immune responses that were noninferior to those in young adults. (Funded by the Biomedical Advanced Research and Development Authority and National Institute of Allergy and Infectious Diseases; KidCOVE ClinicalTrials.gov number, NCT04796896.).

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Viral gastroenteritis research and epidemiology Vaccine Coverage and Hesitancy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 387, Issue 18, pp. 1673-1687

DOI: 10.1056/nejmoa2209367

Field-Weighted Citation Impact: 13.55